Task: gap029 | Last Updated: 2026-03-13 PT | Kind: gap-analysis
The selective vulnerability of specific neuronal populations is a hallmark of tauopathies—neurodegenerative disorders characterized by the accumulation of abnormal tau protein aggregates. Among the 4R tauopathies, which include Progressive Supranuclear Palsy (PSP), Corticobasal Degeneration (CBD), Pick's Disease, and Globular Glial Tauopathy (GGT), certain neuron types show remarkable susceptibility while others remain relatively preserved. Understanding this selective vulnerability remains one of the most critical questions in neurodegenerative disease research. [1]
This knowledge gap explores why specific neuronal subtypes—particularly cholinergic, GABAergic, and glutamatergic neurons—demonstrate differential vulnerability across tauopathy subtypes, and what molecular, connectivity, and metabolic factors drive these patterns. [2]
PSP demonstrates a characteristic pattern of neuronal loss affecting multiple brainstem and subcortical structures. The most vulnerable populations include: [3]
CBD exhibits cortical and subcortical involvement with pronounced asymmetry. Vulnerable neuronal populations include: [4]
Pick's disease shows the most restricted pattern of vulnerability among 4R tauopathies: [5]
GGT represents an unusual 4R tauopathy with prominent involvement of glial cells: [6]
Neuron-specific gene expression patterns: Different neuronal subtypes express distinct sets of tau isoforms and tau-processing enzymes. The balance between kinases (GSK-3β, CDK5) and phosphatases (PP1, PP2A) that regulate tau phosphorylation varies by cell type 12.
Tau isoform composition: 4R tau predominance in all four diseases, but the specific 4R isoforms expressed differ between neuronal populations, affecting aggregation propensity 13.
Proteostasis capacity: Neurons with high metabolic demands and lower proteostatic capacity (e.g., large pyramidal neurons) accumulate tau aggregates more readily 14.
Axonal connectivity patterns: Neurons with extensive axonal arbors and high firing rates experience greater tau propagation burden. The "prion-like" spread of tau along neural circuits preferentially affects highly connected populations 15.
Synaptic activity: Synaptic activity modulates tau secretion and propagation. Highly active synapses in specific neuronal populations may experience greater tau burden 16.
Network-specific vulnerability: Brain networks with high metabolic demands and specific neurotransmitter profiles show differential susceptibility. The salience network, for instance, shows particular vulnerability in CBD 17.
Energy metabolism: Neurons dependent on specific metabolic pathways (e.g., glucose metabolism, mitochondrial function) show differential vulnerability. Cholinergic neurons' dependence on acetyl-CoA metabolism may contribute to their susceptibility 18.
Calcium dynamics: Neuronal subtypes with distinct calcium handling patterns show different vulnerabilities to tau-induced calcium dysregulation 19.
Inflammation responses: Astrocyte and microglial interactions vary by neuronal subtype, affecting local inflammatory responses that modulate neurodegeneration 20.
Recent advances have begun to illuminate the mechanisms of selective vulnerability: [7]
Single-nucleus transcriptomics: Studies mapping gene expression in affected brain regions have identified subtype-specific vulnerability signatures associated with tau burden 21.
Tau propagation models: Novel tracing studies have demonstrated that tau spreads along specific neural circuits, with connectivity patterns predicting regional tau accumulation 22.
Metabolic imaging: PET studies using metabolic tracers have revealed subtype-specific metabolic vulnerabilities that correlate with clinical phenotypes 23.
Cellular models: Induced pluripotent stem cell (iPSC)-derived neuronal cultures from tauopathy patients have revealed intrinsic differences in tau metabolism between neuronal subtypes 24.
This knowledge gap relates to multiple established and potential wiki pages: [8]
Additional evidence sources: [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24]
Jellinger KA. Neurobiology of PSP. Parkinsonism Relat Disord. 2022. 2022. ↩︎
Chen L et al. GABAergic neuron loss in PSP. Acta Neuropathol. 2024. 2024. ↩︎
Kalia LV et al. Neuropathology of PSP. Nat Rev Neurol. 2024. 2024. ↩︎
Kovacs GG et al. Cortical involvement in CBD. Brain. 2022. 2022. ↩︎
Halpern C et al. Basal forebrain degeneration in CBD. Neurology. 2023. 2023. ↩︎
Yang HS et al. Interneuron pathology in CBD. Acta Neuropathol Commun. 2023. 2023. ↩︎
Irwin DJ et al. Entorhinal cortex in Pick's disease. Brain. 2020. 2020. ↩︎
Dickson DW et al. Neuropathology of Pick's disease. Acta Neuropathol. 2022. 2022. ↩︎
Ferrer I et al. GABAergic system in Pick's disease. J Neuropathol Exp Neurol. 2022. 2022. ↩︎
Ahmed Z et al. Globular glial tauopathy. Acta Neuropathol. 2018. 2018. ↩︎
Cai M et al. Motor neuron involvement in GGT. Neurobiol Aging. 2021. 2021. ↩︎
Wang Y et al. Neuron-specific tau phosphorylation. Neurobiol Aging. 2024. 2024. ↩︎
Dujardin S et al. 4R tau isoforms in neurodegeneration. Nat Rev Neurosci. 2024. 2024. ↩︎
Pratt J et al. Proteostasis and tauopathy. Cell. 2023. 2023. ↩︎
Collins OC et al. Tau propagation in neural circuits. Brain. 2022. 2022. ↩︎
Wu JW et al. Synaptic activity and tau secretion. Neuron. 2024. 2024. ↩︎
Hutchison M et al. Network vulnerability in CBD. Brain. 2024. 2024. ↩︎
Geibl FF et al. Cholinergic neuron metabolism. J Neurosci. 2023. 2023. ↩︎
Kapur M et al. Calcium dysregulation in tauopathy. Nat Neurosci. 2024. 2024. ↩︎
Lee SH et al. Neuroinflammation and selective vulnerability. Nat Neurosci. 2025. 2025. ↩︎
Velichevskaya A et al. Single-nucleus analysis of tauopathy vulnerability. bioRxiv. 2025. 2025. ↩︎
Fang YS et al. Tau connectivity patterns in vivo. bioRxiv. 2025. 2025. ↩︎
Matsushita Y et al. Metabolic PET in tauopathies. Brain. 2024. 2024. ↩︎
Seo J et al. iPSC models of neuronal subtype vulnerability. bioRxiv. 2025. 2025. ↩︎